Buyer Discovery
Find the right buyers in seconds, tailored to your products. QYOBO reveals cross-selling opportunities and shows who each buyer already works with — so you can focus on the deals that matter.
Identify qualified leads and boost your win rate with unique insights on their business. Here’s how QYOBO helps.
QYOBO identifies the most relevant buyers for your finished drugs, APIs, excipients, or starting materials — tailored to your product portfolio. It highlights cross-selling potential, monitors API prices worldwide, and shows who each buyer already sources from — so you can focus on the most relevant opportunities.
Access unmatched demand intelligence on more than 20,000 pharmaceutical companies worldwide. From finished drugs to APIs, excipients, and KSMs, QYOBO delivers a continuously updated, unified view of every company’s procurement demand — powered by over 300 databases globally. See total demand across all subsidiaries and affiliates in one place, and uncover buyers your competitors don’t even know exist.
Focus on the buyers that matter most. QYOBO’s Sales Match automatically compares your product portfolio with the purchasing demand of tens of thousands of companies around the world. Instantly uncover new leads or cross-selling opportunities with existing customers.
Understand the competitive landscape for every company you target. With QYOBO’s supply chain intelligence, you can see their existing suppliers and whether they are single-sourced or overexposed to certain competitors or regions. Analyze the full value chain — which company supplies the API to a FDF manufacturer and which MA holders depend on them downstream — to gain a clear view of where the strongest opportunities lie.
Identify the most attractive buyers and markets with precision. QYOBO provides continuously updated, country-level pricing intelligence to reveal where your products achieve the best margins. Track price trends, focus on the most profitable markets, and stay ahead of the competition.
Turn insights into results directly within QYOBO. Create and track opportunities directly in the platform, assign them to your sales team, and follow progress through every stage — all in one place. Capture key details like target price, volume, and existing suppliers, and integrate seamlessly with CRMs like Salesforce to ensure no opportunity is left untouched.
Benefits
While Others Drown in Data, You’re Already Making the Right Moves.
Gain a complete view of the global buyer landscape with intelligence on more than 20,000 pharmaceutical companies — from finished drugs to APIs, excipients, and KSMs. QYOBO consolidates procurement data from over 300 sources, giving you full visibility into who buys what, where, and from whom — so you uncover opportunities no one else can see.
QYOBO automatically matches your portfolio to real buyer demand, helping you focus on the leads that matter most. Automatically identify single-sourced buyers and uncover cross-selling opportunities — driving higher conversions with precision targeting. With full visibility into prices, competitors, and sourcing dependencies, your proposals become smarter, sharper, and far more likely to win.
Stay ahead in a constantly evolving market. QYOBO updates in near real-time, giving you insights into changing demand, price trends, and competitor activity. Purpose-built for commercial effectiveness, QYOBO turns intelligence into action through its integrated sales pipeline — ensuring every opportunity is captured.
Success Story
QYOBO transforms how Sinopep tracks new market entrants and understands competitive market dynamics.
“We were really lacking transparency in the market, particularly in the peptide drug market. We were looking for more efficient ways of identifying potential customers. Previously, we would spend hours or days just trying to put together some list of new customers. But with the QYOBO platform, it’s a much more efficient process.”
Connor Thomson
Director of Peptides
More capabilities
One Platform. From Insight to Action.
See how QYOBO transforms pharma decision-making with AI-driven insights.
Questions?
Absolutely. QYOBO shows each buyer’s current supplier network down to a site-level, helping you identify single-sourced or overexposed companies. This allows you to target opportunities where you can offer a strong alternative to increase supply security.
QYOBO automatically compares your product portfolio with the purchasing activity of your existing customers worldwide. It highlights where you’re already doing business — alongside products you also manufacture but that they currently source from other suppliers — revealing immediate cross-selling opportunities to strengthen and expand your relationship.
Yes. QYOBO processes and analyzes data from more than 300 sources covering over two million drugs worldwide — an amount of information that’s humanly impossible to capture or monitor manually.
By connecting these datasets and deducing insights that aren’t directly accessible from individual sources, QYOBO uncovers active buyers across every geography and product type — including many your competitors haven’t even identified yet. The platform is “live”, continuously updating this intelligence and directing your focus to the most promising opportunities right when they appear.
Yes. QYOBO integrates seamlessly with leading CRM systems like Salesforce, allowing you to import opportunities, assign leads, and track progress directly within your existing workflows. There’s no complex data mapping required — QYOBO’s advanced algorithms handle it automatically, so setup takes just a few days instead of a full-scale IT implementation project.
QYOBO continuously processes and validates information from more than 300 regulatory, trade, and market databases worldwide. By cross-referencing, enriching, and updating multiple data streams, it delivers the most comprehensive and reliable buyer intelligence in the pharmaceutical industry — trusted by leading sales organizations such as BASF, Par Pharma, Aspen API, and Medichem.
QYOBO covers the entire pharmaceutical value chain — from MA holders purchasing or licensing finished drugs and APIs, to CMOs sourcing APIs and excipients, and API manufacturers procuring key starting materials (KSMs). This provides a complete, connected view of global demand across every product category, company type, and market segment.
